James Edgemond, CFO AND TREASURER at UNITED THERAPEUTICS Corp (UTHR), sold 10,000 shares at $569.46 ($5.7M) on 2026-05-11, disclosed to the SEC on 2026-05-12.
Scheduled sale ($5.7M) by CFO AND TREASURER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $569.46 | 1,289 | $734K | 12.8% |
| 2 | $570.17 | 2,059 | $1.2M | 20.5% |
| 3 | $571.42 | 1,496 | $855K | 14.9% |
| 4 | $572.32 | 1,356 | $776K | 13.5% |
| 5 | $573.22 | 480 | $275K | 4.8% |
| 6 | $574.57 | 661 |
| $380K |
| 6.6% |
| 7 | $575.26 | 530 | $305K | 5.3% |
| 8 | $576.68 | 89 | $51K | 0.9% |
| 9 | $577.59 | 893 | $516K | 9.0% |
| 10 | $578.42 | 476 | $275K | 4.8% |
| 11 | $579.80 | 591 | $343K | 6.0% |
| 12 | $580.45 | 80 | $46K | 0.8% |
| Total | $573.03 avg | 10,000 | $5.7M | 100% |
| Filing → |
| UTHR | SELL | 2026-06-16 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-12 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-09 | $5.5M | — | Filing → |